当前位置:首页 - 行情中心 - 汇宇制药-W(688553) - 财务分析 - 现金流量表

汇宇制药-W

(688553)

  

流通市值:54.65亿  总市值:67.41亿
流通股本:5.07亿   总股本:6.26亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金736,822,956.7280,233,475.251,115,440,951.67913,898,156.93
  收到的税费返还13,086,644.425,146,499.7116,575,008.6413,021,236.94
  收到其他与经营活动有关的现金101,711,553.6532,865,984.95156,201,919.11104,968,779.22
  经营活动现金流入的平衡项目0.01000
  经营活动现金流入小计851,621,154.78318,245,959.911,288,217,879.421,031,888,173.09
  购买商品、接受劳务支付的现金317,089,052.4678,097,985.63327,967,913.52279,761,178.2
  支付给职工以及为职工支付的现金118,511,933.8366,613,043.46257,972,487.79167,827,687.64
  支付的各项税费38,485,528.3615,811,158.5537,682,759.4157,162,814.03
  支付其他与经营活动有关的现金286,013,950.16137,557,191.16574,081,272.56495,968,159.94
  经营活动现金流出小计760,100,464.81298,079,378.81,197,704,433.281,000,719,839.81
  经营活动产生的现金流量净额平衡项目0-0.0100
  经营活动产生的现金流量净额91,520,689.9720,166,581.190,513,446.1431,168,333.28
二、投资活动产生的现金流量:
  收回投资收到的现金189,439,172.4270,720,000645,990,532.43580,405,909.78
  取得投资收益收到的现金8,206,634.317,584,60441,191,997.23,005,902.03
  处置固定资产、无形资产和其他长期资产收回的现金净额4,156.1730300,256.6583,789.79
  投资活动现金流入小计197,649,962.978,304,634687,482,786.28583,495,601.6
  购建固定资产、无形资产和其他长期资产支付的现金23,318,255.213,457,865.81105,273,826.7882,355,562.18
  投资支付的现金190,888,988.68110,000,000450,820,000363,000,000
  支付其他与投资活动有关的现金--600,000-
  投资活动现金流出小计214,207,243.88123,457,865.81556,693,826.78445,355,562.18
  投资活动产生的现金流量净额-16,557,280.98-45,153,231.81130,788,959.5138,140,039.42
三、筹资活动产生的现金流量:
  取得借款收到的现金454,900,000283,900,000493,146,000390,146,000
  收到其他与筹资活动有关的现金47,771,94048,000,000408,000,000234,925,444.45
  筹资活动现金流入小计502,671,940331,900,000901,146,000625,071,444.45
  偿还债务支付的现金339,046,000185,900,000385,100,000365,004,466.67
  分配股利、利润或偿付利息支付的现金91,865,606.562,271,723.58199,070,599.61194,946,780.04
  支付其他与筹资活动有关的现金59,000,00059,000,000217,026,470165,639,900
  筹资活动现金流出小计489,911,606.56247,171,723.58801,197,069.61725,591,146.71
  筹资活动产生的现金流量净额12,760,333.4484,728,276.4299,948,930.39-100,519,702.26
四、汇率变动对现金及现金等价物的影响-2,655,828.92-1,818,039.13-726,383.543,909,781.69
五、现金及现金等价物净增加额85,067,913.5157,923,586.58320,524,952.4972,698,452.13
  加:期初现金及现金等价物余额2,377,769,199.012,377,769,199.012,057,244,246.522,057,244,246.52
  期末现金及现金等价物余额平衡项目000-0.01
  期末现金及现金等价物余额2,462,837,112.522,435,692,785.592,377,769,199.012,129,942,698.64
补充资料:
  净利润57,063,904.83--30,547,754.14-
  资产减值准备4,293,268.24-5,406,404.61-
  固定资产和投资性房地产折旧50,411,960.12-87,435,439.06-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧50,411,960.12-87,435,439.06-
  无形资产摊销1,107,819.56-2,412,718.17-
  长期待摊费用摊销153,627.21-921,763.68-
  处置固定资产、无形资产和其他长期资产的损失-4,156.17--1,887.15-
  固定资产报废损失--118,576.53-
  公允价值变动损失30,419,505.37-167,003,663.92-
  财务费用6,169,136.04-4,206,892.91-
  投资损失7,639,685.28--477,465.87-
  递延所得税-9,423,780.06--35,352,039.41-
  其中:递延所得税资产减少-3,895,291.87--36,043,845.36-
    递延所得税负债增加-5,528,488.19-691,805.95-
  存货的减少-42,002,473.9--110,201,879.82-
  经营性应收项目的减少-8,842,211.41--41,960,444.74-
  经营性应付项目的增加-8,529,582.86-36,123,615.11-
  其他--1,290,878.57-
  现金的期末余额2,462,837,112.52-2,377,769,199.01-
  减:现金的期初余额2,377,769,199.01-2,057,244,246.52-
  现金及现金等价物的净增加额85,067,913.51-320,524,952.49-
公告日期2026-08-222026-04-252026-04-252025-10-30
审计意见(境内)标准无保留意见
TOP↑